AQUALYX® Cosmetic is presented by Marllor Biomedical as a cosmetic product for topical application. This updated guide offers aesthetic professionals clear information about its current positioning, documentation, authenticity and traceability.

This page is informational and does not replace the instructions, labeling or documentation supplied with the specific product and batch.

What is AQUALYX Cosmetic?

AQUALYX Cosmetic is part of Marllor Biomedical’s professional aesthetic portfolio. The manufacturer currently states topical application only and positions the product within non-surgical cosmetic body-contour care. Product claims and handling information should be checked against the original packaging and current official documentation.

Topical use and transdermal aesthetic equipment

Professional cosmetic services may involve non-invasive transdermal aesthetic equipment where the product instructions and the equipment manufacturer’s recommendations support that combination. Professionals should verify compatibility before combining a particular product with any device.

No universal equipment settings or treatment procedure are provided here. The professional responsible for a service should follow the actual product and device instructions and assess suitability in each case.

Information for professional purchasing

• Product identification: confirm the exact name, presentation and current manufacturer documentation.
• Instructions: check the permitted cosmetic use, labeling and warnings for the market concerned.
• Batch traceability: retain lot information, invoices and related records.
• Storage: follow the conditions stated on the actual packaging.
• Equipment compatibility: verify the instructions of both the product and any transdermal device.

Authenticity and traceability

Marllor Biomedical warns that unauthorized products sold under the AQUALYX Cosmetic name may circulate. Its official website describes a secure QR-code verification process. Follow the authenticity method relevant to the packaging in hand and ask the supplier for documentation if the product’s origin is unclear.

Maintaining a documented supply chain supports product identification, stock management and professional follow-up.

Responsible information for aesthetic professionals

Communications about AQUALYX Cosmetic should reflect the manufacturer’s current presentation and avoid unsupported or guaranteed claims. Professionals should distinguish general cosmetic product information from the assessment required for any particular aesthetic service.

Frequently asked questions

Is this information intended for individual home use?

No. This Glow Health guide is addressed to professionals. The current product labeling and the applicable rules govern use and supply for each presentation.

Can the product be combined with transdermal devices?

Only if the relevant manufacturer documentation supports that combination. This article does not verify compatibility with any specific equipment.

How can authenticity be checked?

Check the original packaging, batch identification and the verification mechanism published by Marllor Biomedical for the presentation supplied.

Related professional guides from Glow Health

For a deeper review of topical-use precautions, documentation and equipment compatibility, read our AQUALYX Cosmetic safety guide for aesthetic professionals. This article focuses on responsible information for professional cosmetic services and does not provide procedural instructions.

For authenticity checks, batch recording and product traceability, consult our professional AQUALYX Cosmetic authenticity and traceability checklist. Verify the current product and manufacturer documentation before placing orders or providing services.

Product information and availability

For product information and commercial availability, see the AQUALYX category at Glow Health. The actual product labeling should always prevail over general editorial descriptions.

Official manufacturer source: Marllor Biomedical — AQUALYX Cosmetic.

Editorial revision: October 2026. This page replaces older procedural information and is not a substitute for current product documentation.